First assessment of classical swine fever marker vaccine candidate CP7_E2alf for oral immunization of wild boar under field conditions

Vaccine

Volumn 32, Issue 18, 2014, Pages 2050-2055

  Feliziani, Francesco ^a   Blome, Sandra ^b   Petrini, Stefano ^a   Giammarioli, Monica ^a   Iscaro, Carmen ^a   Severi, Giulio ^a   Convito, Luca ^c   Pietschmann, Jana ^b   Beer, Martin ^b   De Mia, Gian Mario ^a  

^a ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELL UMBRIA E DELLE MARCHE   (Italy)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^c Servizio gestione faunistica e protezione ambientale Provincia di Perugia   (Italy)

Author keywords

Classical swine fever virus (CSFV); CP7_E2alf; Field trial; Marker vaccine candidate; Oral immunization; Wild boar

Indexed keywords

CP7_E2ALF VIRUS VACCINE; IOPHENOXIC ACID; LIVE VACCINE; MARKER VACCINE; NEUTRALIZING ANTIBODY; OCTOPAMINE; OXYTETRACYCLINE; UNCLASSIFIED DRUG; VIRUS RNA; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL HUNTING; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CATTLE FARMING; CONTROLLED STUDY; ENVIRONMENTAL TEMPERATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEEDING; FEMALE; GOOD MANUFACTURING PRACTICE; INCUBATOR; LABORATORY DIAGNOSIS; LIMIT OF DETECTION; MALE; NONHUMAN; OUTCOME ASSESSMENT; PESTIVIRUS; PLEURA FLUID; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROOM TEMPERATURE; SEROCONVERSION; SEROPREVALENCE; TONSIL; TRANSGENIC ORGANISM; VACCINATION; VIRAL DISEASE ELISA KIT; VIRUS DETECTION; VIRUS TITRATION; WILD BOAR;

CLASSICAL SWINE FEVER VIRUS (CSFV); CP7_E2ALF; FIELD TRIAL; MARKER VACCINE CANDIDATE; ORAL IMMUNIZATION; WILD BOAR;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; CLASSICAL SWINE FEVER; DRUG STABILITY; FEMALE; ITALY; MALE; SUS SCROFA; SWINE; TEMPERATURE; VACCINATION; VIRAL VACCINES;

EID: 84896548363     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.02.006     Document Type: Article

References (26)

1. Lindenbach B.D., Thiel H.J., Rice C.M. Flaviviridae: the viruses and their replication. Fields virology 2007, 1101-1152. Lippincott-Raven Publishers, Philadelphia, PA. 5th ed. D.M. Knipe, P.M. Howley (Eds.).
2. Biagetti M., Greiser-Wilke I., Rutili D. Molecular epidemiology of classical swine fever in Italy. Vet Microbiol 2001, 83(November (3)):205-215.
3. Fritzemeier J., Teuffert J., Greiser-Wilke I., Staubach C., Schluter H., Moennig V. Epidemiology of classical swine fever in Germany in the 1990. Vet Microbiol 2000, 77(November (1-2)):29-41.
4. Laddomada A. Incidence and control of CSF in wild boar in Europe. Vet Microbiol 2000, 73(April (2-3)):121-130.
5. Laddomada A., Patta C., Oggiano A., Caccia A., Ruiu A., Cossu P., et al. Epidemiology of classical swine fever in Sardinia: a serological survey of wild boar and comparison with African swine fever. Vet Rec 1994, 134(February (8)):183-187.
6. Simon G., Le Dimna M., Le Potier M.F., Pol F. Molecular tracing of classical swine fever viruses isolated from wild boars and pigs in France from 2002 to 2011. Vet Microbiol 2013, 166(October (3-4)):631-638.
7. Rossi S., Fromont E., Pontier D., Cruciere C., Hars J., Barrat J., et al. Incidence and persistence of classical swine fever in free-ranging wild boar (Sus scrofa). Epidemiol Infect 2005, 133(June (3)):559-568.
8. Zupancic Z., Jukic B., Lojkic M., Cac Z., Jemersic L., Staresina V. Prevalence of antibodies to classical swine fever, Aujeszky's disease, porcine reproductive and respiratory syndrome, and bovine viral diarrhoea viruses in wild boars in Croatia. J Vet Med B Infect Dis Vet Public Health 2002, 49(June (5)):253-256.
9. von Ruden S., Staubach C., Kaden V., Hess R.G., Blicke J., Kuhne S., et al. Retrospective analysis of the oral immunisation of wild boar populations against classical swine fever virus (CSFV) in region Eifel of Rhineland-Palatinate. Vet Microbiol 2008, 132(November (1-2)):29-38.
10. Blome S., Gabriel C., Staubach C., Leifer I., Strebelow G., Beer M. Genetic differentiation of infected from vaccinated animals after implementation of an emergency vaccination strategy against classical swine fever in wild boar. Vet Microbiol 2011, 153(December (3-4)):373-376.
11. Kaden V., Heyne H., Kiupel H., Letz W., Kern B., Lemmer U., et al. Oral immunisation of wild boar against classical swine fever: concluding analysis of the recent field trials in Germany. Berl Munch Tierarztl Wochenschr 2002, 115(May-June (5-6)):179-185.
12. Rossi S., Pol F., Forot B., Masse-Provin N., Rigaux S., Bronner A., et al. Preventive vaccination contributes to control classical swine fever in wild boar (Sus scrofa sp.). Vet Microbiol 2010, 142(April (1-2)):99-107.
13. Beer M., Reimann I., Hoffmann B., Depner K. Novel marker vaccines against classical swine fever. Vaccine 2007, 25(July (30)):5665-5670.
14. Reimann I., Depner K., Trapp S., Beer M. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus. Virology 2004, 322(April (1)):143-157.
15. Koenig P., Hoffmann B., Depner K.R., Reimann I., Teifke J.P., Beer M. Detection of classical swine fever vaccine virus in blood and tissue samples of pigs vaccinated either with a conventional C-strain vaccine or a modified live marker vaccine. Vet Microbiol 2007, 120(March (3-4)):343-351.
16. Koenig P., Lange E., Reimann I., Beer M. CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV). Vaccine 2007, 25(April (17)):3391-3399.
17. Leifer I., Lange E., Reimann I., Blome S., Juanola S., Duran J.P., et al. Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization. Vaccine 2009, 27(November (47)):6522-6529.
18. Tignon M., Kulcsar G., Haegeman A., Barna T., Fabian K., Levai R., et al. Classical swine fever: comparison of oronasal immunisation with CP7E2alf marker and C-strain vaccines in domestic pigs. Vet Microbiol 2010, 142(April (1-2)):59-68.
19. König P., Blome S., Gabriel C., Reimann I., Beer M. Innocuousness and safety of classical swine fever marker vaccine candidate CP7_E2alf in non-target and target species. Vaccine 2011, 30(December (1)):5-8.
20. Blome S., Aebischer A., Lange E., Hofmann M., Leifer I., Loeffen W., et al. Comparative evaluation of live marker vaccine candidates CP7_E2alf and flc11 along with C-strain Riems after oral vaccination. Vet Microbiol 2012, 158(July (1-2)):42-59.
21. Eble P.L., Geurts Y., Quak S., Moonen-Leusen H.W., Blome S., Hofmann M.A., et al. Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: protection and DIVA characteristics. Vet Microbiol 2013, 162(March (2-4)):437-446.
22. Kaden V., Renner C., Rothe A., Lange E., Hanel A., Gossger K. Evaluation of the oral immunisation of wild boar against classical swine fever in Baden-Wurttemberg. Berl Munch Tierarztl Wochenschr 2003, 116(September-October (9-10)):362-367.
23. Sage M., Fourel I., Lahoreau J., Siat V., Berny P., Rossi S. Iophenoxic acid derivates as markers of oral baits to wildlife. Environ Sci Pollut Res 2013, 20:2893-2904.
24. Paton D.J., McGoldrick A., Greiser-Wilke I., Parchariyanon S., Song J.Y., Liou P.P., et al. Genetic typing of classical swine fever virus. Vet Microbiol 2000, 73(April (2-3)):137-157.
25. Renson P., Le Dimna1 M., Keranflech A., Cariolet R., Koenen F., Le Potier M-F. CP7_E2alf oral vaccination confers partial protection against early classical swine fever virus challenge and interferes with pathogeny-related cytokine responses. Vet Res 2013, 44:9.
26. Aebischer A., Muller M., Hofmann M.A. Two newly developed E(rns)-based ELISAs allow the differentiation of classical swine fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies. Vet Microbiol 2013, 161(January (3-4)):274-285.